Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07DNX
|
||||
Former ID |
DNC012609
|
||||
Drug Name |
PD-115199
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527717] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H32N6O4S
|
||||
Canonical SMILES |
CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)S(=O)(=O)<br />N(C)CCN(C)C
|
||||
InChI |
1S/C22H32N6O4S/c1-6-12-27-20-18(21(29)28(13-7-2)22(27)30)23-19(24-20)16-8-10-17(11-9-16)33(31,32)26(5)15-14-25(3)4/h8-11H,6-7,12-15H2,1-5H3,(H,23,24)
|
||||
InChIKey |
RWNRBPFXDDCJTH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [527717] | |
Adenosine A1 receptor | Target Info | Inhibitor | [527717] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [527717] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Parkinson's disease | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Alcoholism | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.